IT'S NEVER BEEN
A BETTER TIME
TO BE A MICROBIOLOGIST
The discovery of novel native microbial systems has now triggered a gold rush, whereby unique microorganisms can be used for the optimal production of molecules and their analogues, aiming to be explored for applications ranging from powerful medicines to food ingredients. At the same time, start ups like our group and other partners constitute the new R&D providers to large Biotech groups and Pharmaceutical companies. Bearing this in mind, Cluster Biotechnology has entered into a collaboration with one of the largest global probiotic suppliers, aiming to innovate in the medicinal cannabis field and other areas. We are excited about this opportunity, which was strategically and properly designed throughout 2019, and now we prepare to work towards bringing down the costs of important medications, while increasing their global availability. In addition, our first commercial outcome should be released within 12 months, followed by two other aims being later brought to market. A new facility has been established with support from the QLD State Government, which will now combine biodiscovery and genetic engineering to create relevant outcomes for individuals, companies and governments. Contact us to find out more, and check our news space for regular updates.
Natural molecules found in Australia and overseas are being used for the development of innovative medicines, treatment options and medical devices. In addition, purified compounds will be soon tested and disclosed, as they are obtained through our proprietary systems.
AUSTRALIAN POULTRY INNOVATION TRIALS
FUNDED BY THE QLD STATE GOVERNMENT